| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Rigel Pharmaceuticals Inc (RIGL) has 11 insiders with recent SEC Form 4 filings, including 0 buys and 7 sells. RIGL is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 31.7K | $834.7K | - | |
| CFO | 14.3K | $375.5K | - | |
| ? | 12.7K | $335.0K | - | |
| ? | 12.5K | $329.1K | - | |
| ? | 10.6K | $279.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 20, 2018 | Duliege Anne-Marie | EVP &Chief Medical Officer | Sell | 5,000 | $4.11 | $20,550.00 | -100% | |
| Nov 3, 2017 | Maynard Ryan D75 | EVP &CFO | Sale+OE | 100,000 | $3.90 | $390,000.00 | -100% | |
| Jul 5, 2017 | Duliege Anne-Marie | Chief Medical Officer | Sell | 5,000 | $2.69 | $13,427.00 | -100% | |
| Jan 3, 2017 | Duliege Anne-Marie | Chief Medical Officer | Sell | 5,000 | $2.41 | $12,027.50 | -100% | |
| Aug 30, 2016 | Payan Donald G | EVP, Pres. Discovery&Research | Sell | 5,303 | $4.00 | $21,214.12 | -9.1% | |
| Jun 10, 2015 | Payan Donald G | EVP, Pres. Discovery&Research | Sale+OE | 41,666 | $3.68 | $153,214.22 | -41.7% | |
| Apr 1, 2015 | Payan Donald G | EVP, Pres. Discovery&Research | Sell | 10,000 | $3.75 | $37,518.00 | -14.6% |